HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immature platelet fraction: A useful marker for identifying the cause of thrombocytopenia and predicting platelet recovery.

AbstractINTRODUCTION:
The assessment of bone marrow thrombopoietic activity in patients with thrombocytopenia is necessary to achieve an accurate diagnosis and administer effective treatment. We evaluated the discriminatory power of the immature platelet fraction (IPF) in differentiating hyperdestructive/consumptive thrombocytopenia from hypoproductive thrombocytopenia and its potential use as a predictive marker for platelet recovery.
METHODS:
In this observational study, platelet indices, including IPF, were measured in 105 healthy individuals, 27 patients with hyperdestructive/consumptive thrombocytopenia (all with immune thrombocytopenic purpura [ITP]), and 35 patients with hypoproductive thrombocytopenia (5 with aplastic anemia and 30 with cancer who were undergoing chemotherapy) using a Sysmex XN-3000 hematology analyzer.
RESULTS:
The platelet distribution width, mean platelet volume, platelet large cell ratio, IPF, and absolute immature platelet count (AIPC) were significantly higher in the hyperdestructive/consumptive thrombocytopenia group than in the hypoproductive thrombocytopenia group (Pā€Š<ā€Š.001). The IPF showed the highest difference between the two patient groups (200%). Receiver operating characteristics analysis that showed the IPF had the largest area under the curve among all the platelet indices analyzed; its cut-off value was 2.3%. The IPF decreased 3 to 4 days in advance of platelet count elevation in patients with ITP, whereas the delta AIPC increased 3 days in advance. Furthermore, the IPF and delta AIPC increased 5.5 days and 8.5 days, respectively, before platelet counts increased up to 130.0ā€Š×ā€Š10/L in cancer patients receiving chemotherapy.
CONCLUSION:
These data demonstrated that the IPF and delta AIPC are both excellent indicators of the etiology of thrombocytopenia and predictive markers for platelet recovery.
AuthorsKibum Jeon, Miyoung Kim, Jiwon Lee, Jee-Soo Lee, Han-Sung Kim, Hee Jung Kang, Young Kyung Lee
JournalMedicine (Medicine (Baltimore)) Vol. 99 Issue 7 Pg. e19096 (Feb 2020) ISSN: 1536-5964 [Electronic] United States
PMID32049816 (Publication Type: Journal Article, Observational Study)
Chemical References
  • Biomarkers
Topics
  • Adult
  • Aged
  • Anemia, Aplastic (blood, complications, diagnosis)
  • Biomarkers (blood)
  • Case-Control Studies
  • Female
  • Humans
  • Male
  • Mean Platelet Volume
  • Middle Aged
  • Neoplasms (complications)
  • Platelet Count
  • Predictive Value of Tests
  • Purpura, Thrombocytopenic, Idiopathic (blood, diagnosis)
  • ROC Curve

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: